- Solriamfetol, sold
under the
brand name
Sunosi, is a wakefulness-promoting
medication used in the
treatment of
excessive sleepiness related to narcolepsy...
-
total net
product sales. In 2019, Jazz was
granted FDA-approval to
market Sunosi with
indications for
treating excessive daytime sleepiness (EDS) in narcolepsy...
-
Prolintane (Promotil, Katovit)
Pyrovalerone (Centroton, Thymergix)
Solriamfetol (
Sunosi)
Tametraline (CP-24,411) WY-46824
Amphetamine and many of its immediate...
-
Retrieved 2013-07-19. "Jazz
Pharmaceuticals Announces U.S. FDA
Approval of
Sunosi™ (solriamfetol) for
Excessive Daytime Sleepiness ****ociated with Narcolepsy...
-
Island (FL):
StatPearls Publishing, PMID 30285371,
retrieved 2024-08-15 "
Sunosi: Side effects, alternatives, uses, dosage, and more". www.medicalnewstoday...
- SNG-12 (Synapsinae) –
glycine transporter 1 (GlyT1)
inhibitor Solriamfetol (
Sunosi; JZP-110; SKLN05; ARL-N05; YKP-10A; R-228060; ADX-N05) – norepinephrine...
-
reuptake inhibitor Solriamfetol (ADX-N05, ARL-N05, JZP-110, SKL-N05;
Sunosi) – norepinephrine–dopamine
reuptake inhibitor CX-717 – am****ne / AMPA receptor...
